Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia

Uzbekistan, the most populous country in central Asia, was the first in the region to introduce rotavirus vaccine into its national immunization program. Rotarix (GlaxoSmithKline Biologicals, RV1) was introduced in June 2014, with doses recommended at age 2 and 3 months. To evaluate vaccine impact,...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Umid Eraliev, Renat Latipov, Dilorom Tursunova, Annemarie Wasley, Danni Daniels, Umed Ismoilov, Manzura Akramova, Mehri Sultanova, Dilbar Yuldashova, Bahodir Barakaev, Vazira Mutalova, Laziz Tuychiev, Erkin Musabaev, Said Sharapov, Boris Pleshkov, Dovile Videbaek, Shahin Huseynov, Kamola Safaeva, Slavica Mijatovic-Rustempasic, Michael D. Bowen, Umesh D. Parashar, Margaret M. Cortese
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2021-02-01
Serie:	Human Vaccines & Immunotherapeutics
Soggetti:	rotavirus vaccine uzbekistan rotavirus vaccine effectiveness vaccine impact children
Accesso online:	http://dx.doi.org/10.1080/21645515.2020.1776034
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!